Evidence map›Paper›PMID 27965585›Full record

ArticleFrontiers in physiology2016

A Mouse Intra-Intestinal Infusion Model and its Application to the Study of Nanoparticle Distribution.

Ana Sadio, Ana L Amaral, Rute Nunes, Sara Ricardo, Bruno Sarmento, Raquel Almeida, Hidekazu Tsukamoto, José das Neves

Abstract read
In one paragraph

Article in Frontiers in physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana SadioInstituto de Investigação e Inovação em Saúde, Universidade do PortoPorto, Portugal; Institute of Molecular Pathology and Immunology of the University of PortoPorto, Portugal; Faculty of Medicine of the University of PortoPorto, Portugal; Gastroenterology Department, Unidade Local Saúde da GuardaGuarda, Portugal; Gulbenkian Programme for Advanced Medical EducationLisbon, Portugal.
Ana L AmaralInstituto de Investigação e Inovação em Saúde, Universidade do PortoPorto, Portugal; Institute of Molecular Pathology and Immunology of the University of PortoPorto, Portugal.
Rute NunesInstituto de Investigação e Inovação em Saúde, Universidade do PortoPorto, Portugal; Instituto de Engenharia Biomédica, Universidade do PortoPorto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do PortoPorto, Portugal.
Sara RicardoInstituto de Investigação e Inovação em Saúde, Universidade do PortoPorto, Portugal; Institute of Molecular Pathology and Immunology of the University of PortoPorto, Portugal.
Bruno SarmentoInstituto de Investigação e Inovação em Saúde, Universidade do PortoPorto, Portugal; Instituto de Engenharia Biomédica, Universidade do PortoPorto, Portugal; CESPU - Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Instituto Universitário de Ciências da SaúdeGandra, Portugal.
Raquel AlmeidaInstituto de Investigação e Inovação em Saúde, Universidade do PortoPorto, Portugal; Institute of Molecular Pathology and Immunology of the University of PortoPorto, Portugal; Faculty of Medicine of the University of PortoPorto, Portugal; Biology Department, Faculty of Sciences of the University of PortoPorto, Portugal.
Hidekazu TsukamotoDepartment of Pathology, Southern California Research Center for ALPD and Cirrhosis, Keck School of Medicine of the University of Southern CaliforniaLos Angeles, CA, USA; Department of Veterans Affairs Greater Los Angeles Healthcare SystemLos Angeles, CA, USA.
José das NevesInstituto de Investigação e Inovação em Saúde, Universidade do PortoPorto, Portugal; Instituto de Engenharia Biomédica, Universidade do PortoPorto, Portugal.

Funding

USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAPLOWITZ, NEIL · 1995 to 2020
$21.8M
NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

The oral route is the most preferable one when it comes to drug administration. Different animal models have been used to characterize the fate of potential medicines upon oral delivery but fail to clarify specific events occurring at localized sites of the gastrointestinal tract, particularly at the small intestine. We developed a new mouse intra-intestinal infusion model that enabled the direct administration of substances (such as drugs or nanoparticle drug carriers) in the small intestine through an implanted catheter, which can be maintained for prolonged periods of time. The location of catheter insertion can be previously determined as more proximal or distal, allowing to test specific portions of the intestine. Since the model is presumably able to maintain normal physiological characteristics, namely the mucus coating of the intestinal wall, it allowed studying the distribution of different nanoparticles upon localized intra-intestinal administration. The hereby proposed mouse model has the potential to be useful in other types of studies, namely in clarifying localized processes occurring at specific sites of the intestine.

Indexed as

mouse intra-intestinal modelmucoadhesive particlesmucus barriermucus penetrating particlessmall bowel

Identifiers

PMID27965585
PMCPMC5126386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.